Similarly, SGLT1 expression showed significant association with clinical–pathological characteristics and prognosis of ovarian cancer; SGLT1 overexpression significantly correlated with increased pT status and poor prognosis (Lai et al., 2012). This evidence concerns the gene SLC5A1 and ovarian carcinoma.